- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 10th, 2004
Research and Markets has announced the addition of Nanobiotechnology: Opportunities and Technical Analysis to their offering.
Several industries are hindered by the limitations of current technologies. In medicine, clinical diagnostics are often costly and time-consuming. Additionally, most therapeutics lack specificity, and therefore are limited in efficacy and safety. In life science research, the drug discovery process continues to be slowed by existing imaging and screening techniques. Nanobiotechnology promises to provide novel tools and materials that address current technological limitations, and thereby holds great promise for significant advances in both medicine and life science research.
|Related News Press|
Cooling graphene-based film close to pilot-scale production April 30th, 2016
Personal cooling units on the horizon April 29th, 2016
Exploring phosphorene, a promising new material April 29th, 2016